These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26439088)

  • 1. The Genetic Variant I148M in PNPLA3 Is Associated With Increased Hepatic Retinyl-Palmitate Storage in Humans.
    Kovarova M; Königsrainer I; Königsrainer A; Machicao F; Häring HU; Schleicher E; Peter A
    J Clin Endocrinol Metab; 2015 Dec; 100(12):E1568-74. PubMed ID: 26439088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids.
    Luukkonen PK; Nick A; Hölttä-Vuori M; Thiele C; Isokuortti E; Lallukka-Brück S; Zhou Y; Hakkarainen A; Lundbom N; Peltonen M; Orho-Melander M; Orešič M; Hyötyläinen T; Hodson L; Ikonen E; Yki-Järvinen H
    JCI Insight; 2019 Aug; 4(16):. PubMed ID: 31434800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
    Caon E; Martins M; Hodgetts H; Blanken L; Vilia MG; Levi A; Thanapirom K; Al-Akkad W; Abu-Hanna J; Baselli G; Hall AR; Luong TV; Taanman JW; Vacca M; Valenti L; Romeo S; Mazza G; Pinzani M; Rombouts K
    J Hepatol; 2024 Jun; 80(6):941-956. PubMed ID: 38365182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein.
    Johnson SM; Bao H; McMahon CE; Chen Y; Burr SD; Anderson AM; Madeyski-Bengtson K; Lindén D; Han X; Liu J
    Nat Commun; 2024 Jun; 15(1):4847. PubMed ID: 38844467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
    Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
    Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells.
    Rady B; Nishio T; Dhar D; Liu X; Erion M; Kisseleva T; Brenner DA; Pocai A
    PLoS One; 2021; 16(12):e0260721. PubMed ID: 34879108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells.
    Bruschi FV; Tardelli M; Einwallner E; Claudel T; Trauner M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant.
    Jönsson C; Bergram M; Kechagias S; Nasr P; Ekstedt M
    Scand J Gastroenterol; 2024 Jun; 59(6):737-741. PubMed ID: 38563432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
    Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2318619121. PubMed ID: 38657050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression.
    Volkert I; Fromme M; Schneider C; Candels L; Lindhauer C; Su H; Thorhauge K; Pons M; Mohamed MR; Schneider KM; Strnad P; Trautwein C
    Hepatology; 2024 Apr; 79(4):898-911. PubMed ID: 37625151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease.
    Doueiry C; Kappler CS; Martinez-Morant C; Duncan SA
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans.
    Luukkonen PK; Porthan K; Ahlholm N; Rosqvist F; Dufour S; Zhang XM; Lehtimäki TE; Seppänen W; Orho-Melander M; Hodson L; Petersen KF; Shulman GI; Yki-Järvinen H
    Cell Metab; 2023 Nov; 35(11):1887-1896.e5. PubMed ID: 37909034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The health care experience of adults with metabolic dysfunction-associated steatohepatitis and influence of PNPLA3: A qualitative study.
    Stine JG; Medic N; Pettersson B; Venerus M; Blau JE
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
    Cherubini A; Ostadreza M; Jamialahmadi O; Pelusi S; Rrapaj E; Casirati E; Passignani G; Norouziesfahani M; Sinopoli E; Baselli G; Meda C; Dongiovanni P; Dondossola D; Youngson N; Tourna A; Chokshi S; Bugianesi E; ; Della Torre S; Prati D; Romeo S; Valenti L
    Nat Med; 2023 Oct; 29(10):2643-2655. PubMed ID: 37749332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LX-2 Stellate Cells Are a Model System for Investigating the Regulation of Hepatic Vitamin A Metabolism and Respond to Tumor Necrosis Factor
    Czuba LC; Isoherranen N
    Drug Metab Dispos; 2024 Apr; 52(5):442-454. PubMed ID: 38485281
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Geier A; Trost J; Wang K; Schmid C; Krawczyk M; Schiffels S
    Gut; 2024 May; 73(6):1008-1014. PubMed ID: 38458749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.
    Basantani MK; Sitnick MT; Cai L; Brenner DS; Gardner NP; Li JZ; Schoiswohl G; Yang K; Kumari M; Gross RW; Zechner R; Kershaw EE
    J Lipid Res; 2011 Feb; 52(2):318-29. PubMed ID: 21068004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
    Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids.
    Hehl L; Creasy KT; Vitali C; Scorletti E; Seeling KS; Vell MS; Rendel MD; Conlon D; Vujkovic M; Zandvakili I; Trautwein C; Schneider KM; Rader DJ; Schneider CV;
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38668731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of PNPLA3 and lipid-related transcription factors is dependent upon fatty acid profile in primary bovine hepatocytes.
    Erb SJ; Chandler TL; White HM
    Sci Rep; 2022 Jan; 12(1):888. PubMed ID: 35042927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.